Im Labyrinth dem Ziel entgegen: Doxorubicin/Trabectedin bei Leiomyosarkomen im metastasierten und initial nichtresektablen Stadium (2025) Grabenbauer F, Semrau S Journal article Balancing barriers: Family, career, and gender equality in radiation oncology and radiation research—An interdisciplinary prospective survey among the young workforce (2025) Trommer M, Grohmann M, Fabian A, Ehret F, Hess J, Rückert M, Matschke J, et al. Journal article Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery (2025) Thomann B, Fechter T, Fischer J, Runz A, Roers J, Ludwig U, Grehn M, et al. Journal article Is less more? Revisiting elective nodal irradiation in head and neck cancer (2025) Haderlein M, Frei C, Weissmann T, Weber M, Lutz R, Gostian AO, Müller SK, et al. Journal article, Review article Head and neck squamous cell carcinoma in adults aged 45 or younger—an analysis of two tertiary cancer centres (2025) Frei C, Schnellhardt S, Semrau S, Müller SK, Weber M, Kaufmann J, Fietkau R, et al. Journal article Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group (2025) Elsayad K, Correia D, Theiß U, Baehr A, Besserer A, Micke O, Greve B, et al. Journal article DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancer (2025) Matuschek C, Borm K, Hörner-Rieber J, Dellas K, Duma NM, Dunst J, Fietkau R, et al. Journal article Automated quality assurance of imaging dose and protocol adherence in computed tomography radiotherapy planning using TotalSegmentator-based segmentation (2025) Lackner N, Karius A, Brandt T, Ott O, Putz F, Strnad V, May M, et al. Journal article The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planning (2024) Putz F, Beirami S, Schmidt M, May M, Grigo J, Weissmann T, Schubert P, et al. Journal article, Original article Pembrolizumab and radiochemotherapy in locally advanced cervical cancer-the prospective, randomised KEYNOTE-A18 phase 3 study Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie (2024) Trommer M, Gaasch A, Corradini S Journal article